The Promise of Biosimilar Drugs

2019-01-09T13:51:14+00:00By |Categories: Blog Articles|Tags: |

In 2006, the European Medicines Agency granted its first approval of a biosimilar drug, the human growth hormone, Omnitrope™ (Sandoz), and opened the doors of opportunity for this emerging field of medicine. In 2010, President Obama signed into law the Biosimilars Act, and on March 6, 2015, the FDA formally approved its first biosimilar drug, [...]

Comments Off on The Promise of Biosimilar Drugs

Creating High Performance Pharmacovigilance Teams in Diverse, Global Environments

2019-01-09T13:52:05+00:00By |Categories: Blog Articles|Tags: |

Individuals often interpret the same information and terms in dramatically different ways. Multiple factors drive these variances, including culture, background, education, training, and personal biases. Unfortunately, this means when diverse global teams converge in Drug Safety and Pharmacovigilance environments, it can compromise the accurate capture and reporting of critical safety information if [...]

Comments Off on Creating High Performance Pharmacovigilance Teams in Diverse, Global Environments

Download our Precision Medicine Checklist

Complete the form below to receive a link to download this checklist
close-link

Schedule a call with one of our experts today

Let us know how we can help with your clinical trials
close-link